Search   
MSDS  : L-Glutamic acid, magnesium salt (11), hydrobromide
CAS  : 53459-38-4
SYNONYMS  : * Magnesium glutamate hydrobromide * Psycho-soma
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : MA1330000
CHEMICAL NAME : L-Glutamic acid, magnesium salt (1:1), hydrobromide
CAS REGISTRY NUMBER : 53459-38-4
LAST UPDATED : 198910
DATA ITEMS CITED : 14
MOLECULAR FORMULA : C5-H7-N-O4.Br-H.Mg
MOLECULAR WEIGHT : 250.36
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Magnesium glutamate hydrobromide
* Psycho-soma

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 10795 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,60,1968

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2829 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,60,1968

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 325 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,60,1968

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 6864 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,60,1968

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1565 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,60,1968

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 279 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,60,1968

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 2250 mg/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 14,132,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1125 mg/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 14,132,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 6 gm/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,73,1968

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 12 gm/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., #
alive at weaning per # alive at day 4)
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,73,1968

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 1125 mg/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 14,132,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 2250 mg/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 14,132,1967

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 6 gm/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,73,1968

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 600 mg/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.
(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,
Japan) V.1- 1954- Volume(issue)/page/year: 15,73,1968

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Glutamic acid,N-(p-(1-(2,4-diaminopyrido(3,2-d)pyrimidin-6-ylmethyl)propyl)benzoyl)-, hydrate 88393-05-9
Glutamic acid,N-(p-(((2,4-diamino-6-quinazolinyl)methyl)amino)benzoyl)-, L- 18921-68-1
Glucopyranose, polymers, complex with cobalt 18921-68-1
Glutamic acid,N-(3,5-dichloro-4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)- 528-74-5
L-Glutamic acid, N-((2,4-dichlorophenoxy)acetyl)- 32773-59-4
L-Glutamic acid, didecyl ester, hydrochloride 94856-86-7
L-Glutamic acid, didodecyl ester, hydrochloride 59441-30-4
L-Glutamic acid, diethyl ester, hydrochloride 1118-89-4
L-Glutamic acid, dihexadecyl ester,4-methylbenzenesulfonate 95992-27-1
L-Glutamic acid,N-(L-2-(5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-3,4-dihydrox y- 2-furanyl)glycyl)-,(2R-(2-alpha,3-beta,4-beta,5-alpha))- 77368-58-2
L-Glutamic acid,N-(L-2-(5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)tetrahydro-3,4-dihydrox y-2-furanyl)-N-((3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyrimidinyl)-L-valyl)glycyl )-,(2R-(2-alpha,3-beta,4-beta,5-alpha))- 77368-59-3
L-Glutamic acid,N-(4-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)-2-propynylamino) benzoyl)- 112887-62-4
L-Glutamic acid,1-(11-beta,17-dihydroxy-3,20-dioxopregn-4-en-21-yl)ester, hydrochloride 112887-62-4
alpha-D-Glucopyranose, 2,3,4,6-tetracetate1-(phenylbis(2-chloroethyl)phosphoramide) 53115-84-7
Glutamic acid, N-(2,5-diiodobenzoyl)- 53115-84-7
Glutamic acid, compd. with 2-(dimethylamino)ethanol(1:2), L- 53115-84-7
Glutamic acid, N-(p-(3,3-dimethyltriazeno)benzoyl)-,diethyl ester, DL- 34136-24-8
L-Glutamic acid, diteradecyl ester, hydrochloride 125401-72-1
Glutamic acid, N-(dithiocarboxy)-, L-, trisodium salt 75808-54-7
Glutamic acid, N-(dithiocarboxy)-, L-, zinc salt,hydrate (2:3:2) 55127-77-0
L-Glutamic acid,N-((4-((ethoxycarbonyl)amino)phenyl)sulfonyl)-,diethyl ester 81865-27-2
L-Glutamic acid,N-((4-((ethoxycarbonyl)amino)phenyl)sulfonyl)-,dimethyl ester 81865-26-1
L-Glutamic acid,N-(L-2-(5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro- 3,4-dihydroxy-2-furanyl)glycyl)-,(2R-(2-alpha,3-beta,4-beta,5-alpha))- 77368-62-8
L-Glutamic acid,N-(L-2-(5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl)-((3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyrimidinyl)-L- valyl)glycyl)-,(2R-(2-alpha,3-beta,4-beta,5-alpha))- 77368-60-6
Glucopyranose, 1-thio-, 1-(3-butenohydroximate)NO-(hydrogensulfate), monopotassium salt, beta-D- 3952-98-5
Glutamic acid, mixed with glucose 3952-98-5
Glutamic acid, N-glycyl-, L-, pyrolyzate 3952-98-5
Glutamic acid, N-hydrogenated tallowyl-, L-,monosodium salt 3952-98-5
L-Glutamic acid, N-(2-hydroxybenzoyl)- 3441-69-8
L-Glutamic acid, N-((5-hydroxy-3-pyridinyl)carbonyl)- 112193-35-8
Glutamic acid,5-(2-(alpha-hydroxy-p-tolyl)hydrazide), L- 2757-90-6
L-Glutamic acid, compd. with 5-hydroxy-L-tryptophan(1:1), monohydrate 60575-35-1
L-Glutamic acid, N-(3-hydroxy-L-tyrosyl)-, hydrate(2:1) 52370-53-3
Glutamic acid, N-(o-iodobenzoyl)- 52370-53-3
Glutamic acid, N-(p-iodobenzoyl)- 52370-53-3
Glucopyranose, 1-thio-, 1-hydrocinnamohydroximateNO-(hydrogen sulfate), beta-D- 499-30-9
Glutamic acid, iron (2+) salt (11) 2896-87-9
L-Glutamic acid, N-(N(sup2)-(N-(N-L-isoleucyl-L-isoleucyl)-O-phosphono-L-seryl)-L- glutaminyl)-, hydrate 90119-88-3
Glutamic acid, N-lauroyl-, L-, monosodium salt 29923-31-7
Glutamic acid, N-L-leucyl-3-nitro-, sodium salt,hemihydrate (2:2:1) 29923-31-7
Glutamic acid, magnesium salt (11), L- 64407-99-4
L-Glutamic acid, magnesium salt (11), hydrobromide 53459-38-4
Glutamic acid, N-(2-methoxynicotinoyl)- 76980-28-4
Glutamic acid, N-(p-(methylamino)benzoyl)-, sodiumsalt 76980-28-4
Glutamic acid, monoammonium salt, L- 7558-63-6
L-Glutamic acid, monoammonium salt, monohydrate 139883-82-2
Glucopyranose, 1-thio-,1-((S)-3-hydroxy-4-pentenohydroximate) NO-(hydrogensulfate), beta-D- 19237-18-4
L-Glutamic acid, monocalcium salt, tetrahydrate 69704-19-4
L-Glutamic acid, monopiperidinium salt 69704-19-4
Glutamic acid, monopotassium salt, L- 19473-49-5

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net